Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
US Compounding Inc

US Compounding Inc Recalls

All product recalls associated with US Compounding Inc.

Get alerts for this brand

Recall Summary

Total Recalls

65

Past Year

0

Class I (Serious)

1

Most Recent

Dec 2020

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–20 of 65 recalls

Succinylcholine Chloride (US Compounding) – labeling error (2020)

Labeling: Incorrect or Missing lot and/or expiration date: The lot number and BUD were printed in the incorrect position on the product label making it illegible.

FDADec 16, 2020Nationwide• US Compounding Inc

Neostigmine Methylsulfate (US Compounding) – Missing Label (2020)

Labelling: Missing label.

FDANov 25, 2020Nationwide• US Compounding Inc

Ephedrine Sulfate Syringe (US Compounding) – sterility concern (2019)

Lack of assurance of sterility.

Previous

12 3 4

Page 1 of 4Next

Moderate

FDAJan 29, 2019Nationwide• US Compounding Inc

LET Gel 4% (US Compounding) – missing lot information (2019)

Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed as Lot# YYYDDYY@XX with a Beyond Use Date: MM/DD/YYY.

Class IIModerate

FDAJan 24, 2019Nationwide• US Compounding Inc

Docusate Oral Syringe (US Compounding) – Microbial Contamination (2016)

Microbial Contamination of Non-Sterile Products; microbial contamination with B. cepacia

FDAJul 25, 2016TX• US Compounding Inc

Triamcinolone/Lidocaine (US Compounding) – sterility concern (2015)

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class IIModerate

FDASep 12, 2015Nationwide• US Compounding Inc

Methylcobalamin Injection (US Compounding) – sterility concern (2015)

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class IIModerate

FDASep 12, 2015Nationwide• US Compounding Inc

Cyclo/PE/Trop PF (US Compounding) – sterility issue (2015)

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class IIModerate

FDASep 12, 2015Nationwide• US Compounding Inc

Voriconazole Solution (US Compounding) – sterility risk (2015)

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class IIModerate

FDASep 12, 2015Nationwide• US Compounding Inc

Tropicamide/Phenylephrine (US Compounding) – sterility risk (2015)

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class IIModerate

FDASep 12, 2015Nationwide• US Compounding Inc

Omnipaque 300 (US Compounding) – sterility concern (2015)

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class IIModerate

FDASep 12, 2015Nationwide• US Compounding Inc

Pilocarpine Ophthalmic (US Compounding) – sterility issue (2015)

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class IIModerate

FDASep 12, 2015Nationwide• US Compounding Inc

Hyaluronic Acid/Lidocaine (US Compounding) – sterility concern (2015)

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class IIModerate

FDASep 12, 2015Nationwide• US Compounding Inc

Morphine PF (US Compounding) – sterility risk (2015)

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class IIModerate

FDASep 12, 2015Nationwide• US Compounding Inc

Betamethasone SP (US Compounding) – sterility risk (2015)

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class IIModerate

FDASep 12, 2015Nationwide• US Compounding Inc

Betamethasone Combo (US Compounding) – sterility risk (2015)

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class IIModerate

FDASep 12, 2015Nationwide• US Compounding Inc

Cyclo/PE/Tropic/Ketor (US Compounding) – sterility issue (2015)

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class IIModerate

FDASep 12, 2015Nationwide• US Compounding Inc

Alprostadil (US Compounding) – sterility risk (2015)

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class IIModerate

FDASep 12, 2015Nationwide• US Compounding Inc

Brompheniramine Maleate (US Compounding) – sterility issue (2015)

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class IIModerate

FDASep 12, 2015Nationwide• US Compounding Inc

Glycopyrrolate (US Compounding) – sterility concern (2015)

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Class IIModerate

FDASep 12, 2015Nationwide• US Compounding Inc